|
|
|
|
|
by dylandrop
4577 days ago
|
|
The problem is that most science that is funded by private companies is done only to further their funding companies' interests, not those of the general populace. For example, Big Pharma has no incentive to make a cheap cancer cure, it makes too much money off of current cancer treatment. Furthermore, the capitalist approach leads to biased results, again, because research has no incentive at that point to be honest. (Imagine if the only crop research was done by Monsanto.) Capitalism hasn't caused basic research to go away, but if we only rely on science from capitalism, there will undoubtedly be a ton of problems to face there. |
|
It actually does have an incentive to be internally honest, that is, to speak honestly within the corporate entity doing the research. If it isn't honest, it won't work, and what doesn't work can't be monetized (to a first approximation, anyhow; I can come up with crazy exceptions too, but they really are the exceptions). It does have an incentive to be externally dishonest and/or externally silent.
Public research, by contrast, appears to have no particular incentive to be honest either internally or externally. And lo, there's been a whole slew of problems lately about the problems that the largely public research community is facing with honesty, reproducability, and the skewed incentives around publication.
Personally, I think the only defensible position is that both approaches have shown to have serious problems with incentives, and the idea that public researchers are above corruption and have no negative incentives and are just generally "better" than private ones is a point of view that can't stand up to five minutes serious examination. And contrary to naive beliefs about the incorruptibility of politicians controlling the public research funds, both systems have a serious problem with needing to flatter the opinions of the one with the purse strings and make sure not to disprove them too hard. Very, very serious problems.